Astra Generics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.50 M
as on 13-12-2024
About Astra Generics
The Corporate was formerly known as Asha Bulk Drugs And Intermediataries Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Vijay Agge and Pavan Yedhula serve as directors at the Company.
- CIN/LLPIN
U24233TG2011PTC075803
- Company No.
075803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Astra Generics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Agge  | Additional Director | 12-Jul-2023 | Current |
| Pavan Yedhula | Additional Director | 06-Sep-2023 | Current |
Financial Performance of Astra Generics.
Enhance accessibility to Astra Generics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Astra Generics?
Unlock access to Astra Generics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Abhayamm Agritech Private LimitedActive 7 months 25 daysVijay Agge and Pavan Yedhula are mutual person
- Astrica Health Care Private LimitedActive 3 years 4 months
Vijay Agge and Pavan Yedhula are mutual person
- Abhayamm Health Care Private LimitedActive 4 years 6 months
Vijay Agge and Pavan Yedhula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Apr 2022 | ₹2.50 M | Open |
How Many Employees Work at Astra Generics?
Unlock and access historical data on people associated with Astra Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astra Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astra Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
